In Alzheimer's disease (AD) cerebrovascular function is at risk. Transcranial Doppler, near-infrared spectroscopy, and photoplethysmography are noninvasive methods to continuously measure changes in cerebral blood flow velocity (CBFV), cerebral cortical oxygenated hemoglobin (O 2 Hb), and blood pressure (BP). In 21 patients with mild to moderate AD and 20 age-matched controls, we investigated how oscillations in cerebral blood flow velocity (CBFV) and O 2 Hb are associated with spontaneous and induced oscillations in blood pressure (BP) at the very low (VLF ϭ 0.05 Hz) and low frequencies (LF ϭ 0.1 Hz). We applied spectral and transfer function analysis to quantify dynamic cerebral autoregulation and brain tissue oxygenation. In AD, cerebrovascular resistance was substantially higher (34%, AD vs. 
Introduction
In patients with Alzheimer's disease (AD) and in mouse models of AD, the structural integrity of the cerebral vasculature, especially of cortical microvessels, is markedly compromised (Farkas and Luiten, 2001 ). Additionally, dynamic cerebral autoregulation, the vascular mechanism which aims to stabilize brain perfusion, is impaired in mouse models of AD (Han et al., 2008; Iadecola et al., 2009) . Whether dynamic cerebral autoregulation is also altered in human AD remains unknown. Recently, we have shown that patients with early stage AD have a reduced cerebral blood flow velocity (CBFV) and an increased cerebrovascular resistance (CVR) compared with age-matched healthy controls. Moreover, AD patients had smaller spontaneous cerebral blood flow (CBF) oscillations, relative to blood pressure (BP) oscillations. This implies a reduction in transfer function gain, a parameter that quantifies dynamic cerebral autoregulation and describes how changes in BP are transferred to changes in CBF (Claassen et al., 2009a) . Notably, changes in CBF were measured using transcranial Doppler (TCD) in the middle cerebral artery (MCA), reflecting global changes in CBF but not necessarily changes that occur at brain tissue level (van Beek et al., 2008) .
Near-infrared spectroscopy (NIRS) and functional magnetic resonance imaging (MRI) have revealed spontaneous oscillatory changes in cerebral cortical oxygenation (Obrig et al., 2000) . These oscillations appear similar to those observed in CBFV and BP (Reinhard et al., 2006) . However, the exact characteristics of the relationship between dynamic changes in CBFV measured in the basal cerebral arteries and brain tissue oxygenation remains unknown. It is possible that oscillations in brain tissue oxygenation are induced by changes in global CBF and that the dynamic relationship between these variables reflects not only the function of the cerebral vasculature to deliver oxygen to the brain tissue, but also brain tissue oxidative metabolism (Nagata et al., 2002) . We hypothesized that vascular abnormalities in AD may alter this dynamic relationship between CBF and brain tissue oxygenation. In this article we focus on the two different but dependent dynamic relationships, the relation between BP and CBF on the one hand and the relation between CBF and cerebral cortical oxygenation on the other.
CBF velocity in the middle cerebral artery changes dramatically if large changes in BP are induced by changes in body posture from sitting or squatting to upright standing (Claassen et al., 2009b; van Beek et al., 2010) . This provides a model to study not only the relationship between BP and CBF, but also between CBF and cerebral cortical oxygenation. The aim of this study was to test the hypothesis that oscillations in BP and CBF, associated with changes in body posture, are transmitted into changes in brain cortical oxygenation and that this dynamic relationship is altered in patients with mild to moderate AD.
For this purpose, beat-to-beat changes in BP, CBF velocity, and concentrations of frontal cortical oxyhemoglobin (O 2 Hb) and deoxyhemoglobin (HHb) were measured continuously using finger arterial blood pressure measurements, TCD, and NIRS, during repeated sit-stand maneuvers in patients with newly diagnosed AD. Fourier spectral and transfer function analysis were used to quantify the magnitude of oscillations and the dynamic relations between these variables. The repeated sit-stand maneuvers were performed to augment the spontaneous BP and CBFV oscillations (van Beek et al., 2010) . They induce large oscillations in BP, CBFV, and O 2 Hb and enhance the coherence between these variables (Ͼ0.4) and therefore improve the reliability of the transfer function analysis (van Beek et al., 2008) . The repeated sit-stand maneuvers were performed at 0.05 and 0.1 Hz. At the very low frequency (0.05 Hz) dynamic cerebral autoregulation is active, but in the low frequency (0.1 Hz) dynamic cerebral autoregulation is less active (Zhang et al., 1998) .
Methods

Subjects
We recruited 21 AD patients, aged 65 years and older. All patients had been newly diagnosed with AD in the memory clinic at Radboud University Nijmegen Medical Centre. Patients were diagnosed with mild or moderate AD according to the criteria of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA), Clinical Dementia Rating (CDR) 0.5-2 (McKhann et al., 1984) . They were not yet treated with cholinesterase inhibitors. As a control group, 20 agematched healthy old persons were selected from a group of volunteers that responded to a newspaper advertisement. All patients and volunteers were carefully examined by a geriatrician, including physical examination, laboratory evaluation, computerized tomography (CT) (n ϭ 2) or MRI scan (n ϭ 39) of the brain, and neuropsychological testing. All controls and randomly selected patients (n ϭ 10), underwent a Doppler study of the carotid and vertebral arteries to rule out significant stenosis (Ͼ50%).
The study was approved by the Ethics Committee for Research on Human Subjects, Radboud University Nijmegen Medical Centre, and all volunteers and primary caregivers of the AD patients gave written informed consent, and AD patients themselves gave verbal consent.
CBFV and NIRS measurements
Using TCD, CBFV was measured in the MCA. Changes in CBFV represent changes in flow, under the assumption that the diameter of the insonated vessel remains constant. The MCA is 1 of the major conduit arteries of the cerebral circulation and branches directly from the common carotid artery. Many studies have demonstrated that the diameter of the MCA does not change appreciably even during moderate alterations in BP and end-tidal CO 2 (Giller et al., 1993; Newell et al., 1994; Serrador et al., 2000) . Therefore, changes in CBFV should represent predominately changes in CBF in this study. Further, it was assumed that there is no displacement of the MCA with respect to the probe position during repetitive vertical postural changes (Claassen et al., 2009b) .
NIRS measures cerebral cortical changes in O 2 Hb and HHb. The basic principle of NIRS is that near-infrared light penetrates the skull and brain, and is absorbed by the chromophores O 2 Hb and HHb, that have different absorption spectra. Assuming constant scattering, changes in concentration of these chromophores can be deduced, using the modified Lambert-Beer Law (Claassen et al., 2006; Rowley et al., 2007) . The measurements lump all hemoglobin concentration change from a volume of brain under the optodes. This volume might include all types of vessels. However, the actual vessel volume within the examined tissue is very small, and contribution of hemoglobin in conduit vessels to the NIRS signal are negligible. Total hemoglobin (THb), the sum of O 2 Hb and HHb, is associated with local cerebral blood volume, whereas O 2 Hb is associated with local cerebral blood flow (Reinhard et al., 2006) .
We applied a continuous wave NIRS device with 3 light bundles with wavelengths of 775 nm, 845 nm, and 904 nm (Oxymon, Artinis Medical Systems™, Zetten, the Netherlands). A fixed differential path length factor (DPF) of 6.6 (corresponding to age 50) was used in all subjects, which accounts for the increased distance traveled by light due to scattering (Claassen et al., 2006) . At present, no data are available on the actual variation of the DPF with age above 50 years. Our control and patient group, however, were age-matched, which should reduce any systemic measurement bias induced by using a fixed DPF.
Data acquisition
Subjects were in sitting position and received first a 3-lead electrocardiogram (ECG) for measurement of the interval between consecutive R-peaks (RR interval). BP was measured using a photoplethysmography cuff on the index or middle finger of the left hand (Finometer, Finapres Medical Systems, Amsterdam, the Netherlands), with the hand resting approximately at heart level supported by a sling. Data were collected by the Finometer (Finapres Medical Systems) for an uninterrupted period which lasted for a maximum of 5 minutes. Transcranial Doppler ultrasonography was used to measure CBFV. The left and right middle cerebral artery were insonated by placing a 2-MHz Doppler probe (Multi-Dop, Compumedics DWL, Singen, Germany) over the temporal window. The middle cerebral arteries were identified according to their signal depth, velocity, and wave characteristics (Aaslid et al., 1982) . If only 1 signal was available due to 1-sided temporal window failure, we included this available signal for analysis. The probes were locked at a constant angle and position during data collection with a customized headband (Spencer Technologies, Seattle, WA, USA). Two pairs of NIRS optodes were placed and tightly fixed over the left and right frontal cortex in the same headband that locked the Doppler probes. The midpoint between the horizontally positioned pairs was Fp1 for the left pair and Fp2 for the right pair, according to the international 10 -20 electrode system. An interoptode distance of 5.0 cm was used to minimize contamination from the extracerebral circulation and to maximize the signal intensity (Claassen et al., 2006) . NIRS cables and optodes were tightly fixed to prevent movement artifacts. Arterial saturation (SaO 2 ) was recorded with a pulse oxymeter and end tidal CO 2 (EtCO 2 ) using a capnograph (N1000, Nellcor, Boulder, CO, USA). All data were sampled at 125 Hz.
Protocol
From 12 hours before the study, subjects refrained from caffeinated beverages and alcohol. They had a light breakfast at least 2 hours before the visit. All experiments were performed in the morning, in a quiet environmentally-controlled laboratory. After at least 30 minutes of sitting rest, spontaneous oscillations data were collected for 5 minutes. To assess the dynamic pressure flow as well as the flow-brain tissue oxygenation relationship, spontaneous BP and CBFV oscillations were augmented using repeated sit-stand maneuvers at 2 different frequencies (van Beek et al., 2010). Subjects were instructed to perform repeated sit-stand maneuvers at 0.05 Hz (10-second sit followed by 10-second stand) for 5 minutes and at 0.1 Hz (5-second sit followed by 5-second stand) for 4 minutes. Verbal signs were given to facilitate repeated changes in body posture. The maneuvers were separated by 10 minutes for recovery.
Data processing
All data were simultaneously recorded for offline analysis (Oxysoft, Artinis Medical Systems). A running average filter of 1 seconds was applied to the O 2 Hb and HHb signals to increase the signal-to-noise ratio, and to reduce the heart beat and high frequency noise (Claassen et al., 2006; Rowley et al., 2007) .
Spectral analysis was performed on beat-to-beat mean BP, CBFV, O 2 Hb, and HHb changes. The signals were aligned with the time of the R wave peaks of the electrocardiogram (ECG). The time series were then linearly interpolated at 2 Hz to obtain equidistant time intervals and detrended with third-order polynomial fitting. These data then were subdivided into 128 segments with 50% overlap and a Hanning window was applied for spectral estimation. These data segmentations are based on a trade-off between a reduction in spectral variance and keeping sufficient spectral resolution. Each Hanning-windowed segment was fastFourier transformed and the periodograms were averaged to calculate the autospectrum of BP, CBFV, O 2 Hb, and HHb (Zhang et al., 1998) .
For spectral analysis the following frequency ranges were chosen: the very low frequency (VLF) range: 0.02-0.07 Hz for spontaneous oscillations and for the induced 0.05-Hz maneuver, and the low frequency (LF) range: 0.07-0.13 Hz for spontaneous oscillations and for the 0.1-Hz maneuver (van Beek et al., 2010) . Spectral power of oscillations was calculated as area under the curve (AUC) of the power spectral density plots. For comparisons, power spectral density plots of BP, CBFV, O 2 Hb, and HHb were included if data on all signals were available for sitting rest and during both repeated sit-stand maneuvers.
The dynamic relation between BP as input and CBFV as output (BP-CBFV) and the dynamic relation between CBFV as input and O 2 Hb as output (CBFV-O 2 Hb) were determined with transfer function analysis during the repeated sit-stand maneuvers. Because of low coherence, we did not include the calculation of transfer function during spontaneous oscillations of the above dynamic relationships and between CBFV as input and HHb as output (CBFV-HHb) during spontaneous and induced oscillations. Mean values of phase, gain, and coherence of the transfer function were analyzed in the same VLF and LF as described above. We have previously described the explanation of these estimates in detail (Claassen et al., 2009b; van Beek et al., 2008 van Beek et al., , 2010 . In short, the phase shift quantifies the displacement in time of a signal relative to another. The transfer function gain determines the magnitude relationship between 2 signals. Coherence tests the linearity of the relationship between these signals. Coherence approaching unity in a specific frequency suggests a linear relationship, whereas coherence approaching 0 indicates no relationship between the signals, severe extraneous noise, or a nonlinear relationship (Giller and Mueller, 2003) . A coherence of 0.4 is considered the lower limit where transfer function estimates can be calculated with confidence (Zhang et al., 1998) . Estimates of phase, gain, and coherence were therefore only included if coherence was Ͼ0.4 (Table 1 ). All analyses were performed with commercially available software (DADiSP, version 6.0, DSP Development, Cambridge, MA, USA).
Statistical analysis
Data are presented as mean Ϯ SD. Normal distribution was tested using Q-Q plots and could not be assumed for power spectral data of beat-to-beat mean BP, CBFV, O 2 Hb, and HHb. Comparisons between the control and patient group were made using the independent samples t test and the Mann-Whitney U test. For the comparisons of the transfer function estimates between both 0.05 Hz and 0.1 Hz maneuvers a paired samples t test was applied. Statistical significance was set at p Ͻ 0.05. All statistical analysis were performed using statistical software (SPSS version 16.0, SPSS, Inc, Chicago, IL, USA). Table 2 presents the baseline characteristics of patients and controls at screening. Patients and controls were matched for age and blood pressure level at screening (Table 2). Specifically, 15 out of 21 AD patients and 14 out of 20 controls were hypertensive (BP Ͼ140/90) at screening. More AD patients however, used antihypertensive medication (12 vs. 4) and 5 AD patients had diabetes mellitus type 2. As expected, patients had substantially lower cognitive tests scores and more hippocampal atrophy. The difference in age-related white matter score was not significant (⌬ 1.9 on the 30-point scale, p ϭ 0.089). Table 3 provides an overview of the baseline hemodynamics under resting conditions. Heart rate (HR) and BP data could be obtained in all controls and patients. In 1 control and 4 AD patients, data on CBFV could not be obtained due to an insufficient temporal window. Additionally, in 1 AD patient the NIRS measurement had to be excluded because of a low signal-to-noise ratio. Although systolic and diastolic BP (sphygmomanometry) were comparable between AD and controls at screening, mean arterial pressure as obtained from the average of 5 minutes recording at rest using Finometer was higher in AD. Moreover, resting heart rate and spontaneous BP oscillations at the LF range of 0.1 Hz were higher in AD.
Results
Baseline characteristics
Baseline hemodynamic measurements
In patients with AD, despite the higher BP, CBFV was reduced by 10% compared with controls. Consistently, there was a 34% increase in cerebrovascular resistance index in AD (difference ϭ 0.69 [0.25] mm Hg/cm/second, p ϭ 0.012) ( Table 3 ). Alzheimer patients also had larger spontaneous oscillations in CBFV and O 2 Hb at the LF range (Table 3) .
Repeated sit-stand maneuvers
Representative changes in BP, CBFV, and O 2 Hb and HHb during baseline, and the 0.05 Hz and 0.1 Hz sit-stand maneuvers, are presented in Fig. 1 . Note that, as expected, O 2 Hb and HHb oscillate in counterphase, and further that these oscillations appear clearly related to the oscillations in BP and CBFV. Fig. 2 shows the group averaged power spectra of controls and AD. The repeated sit-stand maneuvers induced oscillations in all signals (BP, CBFV, O 2 Hb, and HHb), and the spectral power of these oscillations was significantly larger than for spontaneous oscillations in the corresponding frequency range (Fig. 2) . Notably, the 0.05 Hz repeated maneuver induced the most powerful oscillations. Power spectra for BP, CBFV, O 2 Hb, and HHb were similar in AD and controls in the VLF and LF range (Table 1) . Fig. 3 provides an example of the relation between the oscillations in BP and CBFV, and of the oscillations between CBFV and O 2 Hb during 0.05-Hz sit-stand maneuvers. During this maneuver, oscillations in CBFV led those of BP (phase lead), whereas oscillations in O 2 Hb follow those of CBFV (phase lag), suggesting a time delay between changes in CBF and brain tissue oxygenation.
No differences in transfer function gain and phase between BP and CBFV were observed between controls and AD (Table 1) . Transfer function gain between CBFV and O 2 Hb was higher in AD during the 0.05 Hz repeated sitstand maneuver, and the phase lag between CBFV and O 2 Hb was larger (Table 1 and Fig. 4) . The use of antihypertensive medication in the control and AD group did not lead to within-group differences in gain and phase between CBFV and O 2 Hb (p all Ͼ 0.1). The within-group differences for diabetes in the AD group could not be assessed, because 3 diabetic patients were excluded from transfer function analysis due to low coherence (that is, ultimately, .H.E.A. van Beek et al. / Neurobiology of Aging 33 (2012) 428.e21-428.e31 only 2 patients with [type 2] diabetes were included in the AD group for this part of the analysis).
Discussion
This study assessed dynamic cerebral autoregulation in patients with Alzheimer's disease by means of the concomitant registration of changes in blood pressure, blood flow velocity in the middle cerebral artery, and cerebral frontal cortical oxygenation. There are 3 main findings in this study. First, in view of the fact that the origin of very low frequency oscillations in cortical oxygenation remains disputed, these data demonstrate that these oscillations are related to changes in global CBF, as measured in the middle cerebral artery, and that these CBF changes in turn were related to changes in systemic blood pressure. Second, this study shows that by using repeated sit-stand maneuvers, the dynamic CBF-brain tissue oxygenation relation can be assessed using transfer function analysis with a high coherence function (Ͼ0.4) between these variables. Third, we have shown that how changes in CBF are transmitted to changes in brain tissue oxygenation differs essentially between patients with Alzheimer disease and controls, as evidenced by increased transfer function gain and phase at 0.05 Hz between changes in CBF velocity and cortical O 2 Hb signal.
Oscillations in cerebral and systemic hemodynamics
The NIRS method directly assesses cerebral cortical oxygenation changes at the cerebral cortical tissue level. In accordance with the literature, we detected spontaneous oscillations in O 2 Hb and HHb in the very low and low frequency range, where also spontaneous variability in BP and CBFV can be found (Obrig et al., 2000; Schroeter et al., 2004) . Compared with healthy controls, AD patients had enhanced spontaneous oscillations in BP in the low frequency range (around 0.1 Hz), which led to The repeated sit-stand maneuvers induced large oscillations in O 2 Hb that mirrored those in BP and CBFV. Thus far, only 1 study has succeeded in inducing oscillatory O 2 Hb changes, using deep breathing at 0.1 Hz, and these authors observed similar oscillations in BP, CBFV, and O 2 Hb (Reinhard et al., 2006) . With a repeated sit-stand maneuver, we were able to induce oscillatory O 2 Hb changes in the very low frequency of 0.05 Hz, which would not have been possible with deep breathing. Our data indicate that oscillatory O 2 Hb changes in this frequency range are related to the oscillations in CBFV, which in turn are induced by oscillations in systemic BP. The larger oscillations in BP and CBFV at 0.05 compared with 0.1 Hz during repeated sit-stand maneuvers are in agreement with previous studies (Claassen et al., 2009b; Hamner et al., 2004; van Beek et al., 2010) . Taken together, the relationship between BP, CBFV, and O 2 Hb during repeated sit-stand maneuvers lends support to the notion that upstream oscillations in CBF induced by changes in BP contribute importantly to the downstream brain tissue level oscillations in O 2 Hb.
CBFV and dynamic autoregulation
Confirming previous results from a pilot study measuring only CBFV, we observed that CBFV was reduced and cerebrovascular resistance was increased in AD (Claassen et al., 2009a) . This may be explained by enhanced vasoconstriction and other vascular factors such as a reduced cere- Fig. 2 . Group averaged power spectra of blood pressure, cerebral blood flow velocity, and cortical frontal oxy-and deoxygenated hemoglobin oscillations in sitting rest and during repeated sit-stand maneuvers. Results of spectral analysis of blood pressure (BP; upper panel), cerebral blood flow velocity (CBFV; middle panel), and frontal cortical oxygenated and deoxygenated hemoglobin (O2Hb, black line, and HHb, gray line -both bottom panel) during sitting rest (left), the 0.05 Hz repeated sit-stand maneuver (middle), and the 0.1 Hz repeated sit-stand maneuver (right). The solid lines represent the spectra of the oscillations in healthy controls, the dotted lines are for the Alzheimer's patients. 428.e27 A.H.E.A. van Beek et al. / Neurobiology of Aging 33 (2012) 428.e21-428.e31 bral capillary density and an aberrant vascular repair (Wu et al., 2005) .
We have previously shown that this difference could not be explained by differences in individual whole brain volume (Claassen et al., 2009a) . We could however not reproduce the earlier findings of a lower gain between BP-CBFV during either the 0.05 Hz or 0.1 Hz repeated maneuver in AD relative to controls. An important difference between these studies is that in the present study patients were not treated yet with cholinesterase inhibitors. These drugs potentially alter cerebral hemodynamics (Claassen et al., 2009c) . Moreover, AD patients in the present study were older.
The CBF response to transient changes in BP, as quantified by transfer function gain and phase, reflects dynamic cerebral autoregulation (Zhang et al., 1998) . The mechanisms underlying dynamic autoregulation are not clear. The unaltered gain and phase between BP and CBFV observed in this study suggest that dynamic autoregulation -at least at the macrovascular level -is preserved in patients with AD. However, dynamic cerebral autoregulation was impaired in the mouse models of AD related to beta amyloid pathology (Han et al., 2008; Iadecola et al., 2009 ). These discrepancies may highlight the differences in the regulation of cerebral hemodynamics between patients with AD and the animal model used. Clearly, further work is needed to understand the regulation of CBF and its relation to AD pathology.
The dynamic CBFV-O 2 Hb relationship
The dynamic relation between oscillations in CBFV and cortical O 2 Hb may reflect a regulatory mechanism to maintain brain tissue oxygenation homeostasis (Iadecola et al., 2009; Rowley et al., 2007) . However, the investigation of the relationship between spontaneous oscillations in CBFV and O 2 Hb using transfer function analysis suffers from the weakness and nonstationarity of the O 2 Hb measurement under resting conditions (Rowley et al., 2007) . The repeated sit-stand maneuvers in this study induced large oscillations in BP, CBFV, and O 2 Hb and enhanced coherence between CBFV-O 2 Hb (Ͼ0.4) and therefore improve the reliability of the transfer function analysis (van Beek et al., 2008) .
CBFV was measured in the MCA. NIRS measurement was obtained from the medial-frontal cortex areas which are 428.e28dependent for their blood supply on the anterior cerebral artery (ACA) as well as the MCA. We assumed that relative change of CBFV in the MCA would be the same for the relative change of CBFV in the ACA in response to a change in blood pressure.
O 2 Hb oscillations seem to follow those of CBFV (Fig.  3) . Therefore, the phase difference between these variables may reflect a transit time between flow in supplying brain arteries and O 2 Hb. In patients with AD, a disease in which it becomes progressively clear that the cerebral microvasculature is affected, we identified a larger phase lag and higher gain between CBFV and O 2 Hb at the very low frequency of 0.05 Hz -where dynamic cerebral autoregulation is active -but not in the low frequency (0.1 Hz) -where autoregulation is less active (Zhang et al., 2009) . Because O 2 Hb is a correlate of local blood flow, this might point to a differential transfer of central blood flow to local blood flow and to local cerebral oxygenation in Alzheimer's disease. Whether this is due to differences in active regulation mechanisms or due to differences in the passive properties of the cerebral vasculature is not clear (Mandeville et al., 1999) . The increases in the transfer function gain between CBFV and O 2 Hb provide further insights into the cerebral microvascular function in AD. Using positron emission tomography (PET), it has been shown that the oxygen extraction fraction, regarded as an indicator of the brain tissue metabolic reserve, was increased in AD (a reduction of metabolic reserve) (Nagata et al., 2002) . In addition, reduced brain metabolic rate for glucose and oxygen has been observed in AD which may reduce the oxygen diffusion gradient from the capillaries to brain tissue. Therefore, the increase in CBFV-O 2 Hb gain might also reflect a reduced metabolic reserve or a reduced diffusion of oxygen leading to enhanced oscillations in O 2 Hb in response to changes in CBF.
The specific mechanisms for the altered CBFV-O 2 Hb relationship in AD cannot be determined in this study. Amyloid beta, the peptide linked to the pathological manifestations in AD, causes cerebrovascular dysfunction (Han et al., 2008) as well as deposits in the small vessels in AD (cerebral amyloid angiopathy). In turn, the brain microcirculation not only responds to amyloid beta, but also regulates amyloid beta (Zlokovic et al., 2000) . It is possible that these abnormalities may contribute to the altered CBFV-O 2 Hb relation. Further, the enhanced oscillations of O 2 Hb in response to changes in CBF may lead to local hypoxic changes in the brain that in turn could establish a vicious circle: over expression of transcription factors in smooth muscle cells of small brain arteries promote a hypercontractile phenotype of cerebral arteries, which may increase the cerebrovascular resistance (CVR), and in turn leads to hypoxia (Chow et al., 2007) .
Study limitations
During screening, controls and patients were matched for blood pressure. Significantly more patients used antihypertensive drugs. However, cerebral autoregulation and cerebral blood flow are preserved during treatment with ␤-blockers, calcium channel blockers, angiotensinconverting enzyme inhibitors, AT 1 -recepter blockers, or thiazide diuretics (Estrup et al., 2001; Heinke et al., 2005; Lipsitz et al., 2000; Pandita-Gunawardena and Clarke, 1999; Zhang et al., 2007) .
In the AD group, 5 subjects suffered from type 2 diabetes. Data regarding the influence of diabetes on cerebral autoregulation are mixed, reporting either an impairment or preservation of cerebral autoregulation (Brown et al., 2008; Kim et al., 2008; Marthol et al., 2007) . For the analysis of the relation between CBFV-O 2 Hb at 0.05 Hz -where the current study demonstrated an altered relationship in ADonly 2 diabetic AD patients were included. This makes a confounding effect of diabetes on our findings very unlikely. Moreover, hypertension and diabetes mellitus are the most important vascular risk factors for AD (Viswanathan et al., 2009) , and exclusion of AD patients with such comorbidities from studies would seriously hamper their generalizability. 
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A. H.E.A. van Beek et al. / Neurobiology of Aging 33 (2012) 428.e21-428.e31 Both methods to assess cerebral perfusion, TCD and NIRS, have certain limitations that have been well described in the literature and are summarized in the Methods section. We combined these 2 measurements to provide information on both global cerebral perfusion and brain tissue level oxygenation in patients with AD.
Conclusion
Using a unique combination of Finapres, TCD, and NIRS measurements, we have shown that oscillations in cerebral blood flow velocity, induced by repeated changes in body posture, translated into large oscillations in cerebral cortical oxygenation. Furthermore, the dynamic relation between cerebral blood flow velocity and cerebral cortical oxygenation can be assessed using transfer function analysis during repeated sit-stand maneuvers. Finally, we demonstrated that Alzheimer patients differed from controls in how these changes in flow were transmitted to changes in cerebral cortical oxygenation. This result might be indicative of either altered properties of the cerebral microvasculature or brain tissue oxidative metabolism in patients with Alzheimer disease.
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